Herbal formulation for immunity boosting during pandemic
Not Applicable
Completed
- Registration Number
- CTRI/2020/07/026528
- Lead Sponsor
- Aparna Abhay Raut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
1.Subject willing to give voluntary informed consent
2. Irrespective Sex
3. Healthy Volunteers
4. Health Workers
5. Front line workers during pandemic
6. Subject having travelling history
7. Subject willing to follow the procedure as per the study protocol
Exclusion Criteria
1. COVID 19 positive patient
2. Fever
3. Hypersensitivity or idiosyncratic reaction to any drugs or herbal products
4. History of allergic condition
5. History of psychiatric disorder
6. Presence of abnormal laboratory report
7. Known subject of malignancy
8. Subject of participating in another clinical study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-Number of individuals developing symptoms <br/ ><br>2-Number of individuals turning COVID 19 test positiveTimepoint: 0-enrollment of patient for <br/ ><br> intervention(baseline) <br/ ><br>Follow up after 2 weeks. <br/ ><br>Outcome will be assessed <br/ ><br>1-Baseline- <br/ ><br>2nd-after 4 week <br/ ><br>3rd - after 6 week <br/ ><br>4th-after 8 week <br/ ><br>5th -after 10 week <br/ ><br>6th- after 12 week
- Secondary Outcome Measures
Name Time Method 1 Number of individuals developing symptoms. <br/ ><br>2 Number of individuals turning COVID 19 test positive. <br/ ><br>3 Adverse events. <br/ ><br>4 Improvement in immune status using immune status qustionnaire.Timepoint: secondary outcome will be assessed after 6 month from baseline.